Serum osteoprotegerin levels associated with the aortic augmentation index in renal transplant recipients
- PMID: 28757712
- PMCID: PMC5509171
- DOI: 10.1016/j.tcmj.2015.12.005
Serum osteoprotegerin levels associated with the aortic augmentation index in renal transplant recipients
Abstract
Objectives: Arterial stiffness is recognized as an independent risk factor for cardiovascular morbidity and mortality. Recent studies found that osteoprotegerin (OPG) is associated with arterial stiffness and may reflect endothelial dysfunction. The aim of this study was to evaluate the relationship between fasting serum OPG levels and the aortic augmentation index (AIx) in renal transplant recipients.
Materials and methods: Fasting blood samples were obtained from 66 renal transplant recipients. The aortic AIx was measured using a validated tonometry system (SphygmoCor). Serum OPG levels were measured using a commercial enzyme-linked immunosorbent assay kit.
Results: Univariate linear analysis of the aortic AIx in renal transplant recipients revealed that body fat mass (r = 0.377, p = 0.002), aortic diastolic blood pressure (DBP; r = 0.307, p = 0.020), triglycerides (r = 0.260, p = 0.035), and logarithmically transformed OPG (log-OPG, r = 0.402, p < 0.001) were positively correlated, whereas height (r = 0.361, p = 0.004) and body weight (r = 0.212, p = 0.041) were negatively correlated with the aortic AIx in renal transplant recipients. Multivariate forward stepwise linear regression analysis of the factors significantly associated with the aortic AIx showed that log-OPG (R2 = 0.213, p < 0.001), height (R2 = 0.081, p = 0.009), and aortic DBP (R2 = 0.058, p = 0.022) were independent predictors of the aortic AIx in renal transplant recipients.
Conclusion: These results suggest that the serum fasting OPG level is associated with the aortic AIx in renal transplant recipients.
Keywords: Aortic augmentation index; Kidney transplantation; Osteoprotegerin.
Conflict of interest statement
Conflicts of interest: none.
Similar articles
-
Hyperleptinemia is associated with the aortic augmentation index in kidney transplant recipients.Tzu Chi Med J. 2018 Jul-Sep;30(3):152-157. doi: 10.4103/tcmj.tcmj_9_18. Tzu Chi Med J. 2018. PMID: 30069123 Free PMC article.
-
Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease.Ther Clin Risk Manag. 2018 Feb 5;14:231-236. doi: 10.2147/TCRM.S150476. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29440908 Free PMC article.
-
The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis.Tzu Chi Med J. 2019 Apr-Jun;31(2):102-106. doi: 10.4103/tcmj.tcmj_90_18. Tzu Chi Med J. 2019. PMID: 31007490 Free PMC article.
-
High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients.Tohoku J Exp Med. 2015 Aug;236(4):247-53. doi: 10.1620/tjem.236.247. Tohoku J Exp Med. 2015. PMID: 26156285
-
Inverse Association Between Serum Osteoprotegerin and Bone Mineral Density in Renal Transplant Recipients.Transplant Proc. 2016 Apr;48(3):864-9. doi: 10.1016/j.transproceed.2015.12.069. Transplant Proc. 2016. PMID: 27234754
Cited by
-
Hyperleptinemia is associated with the aortic augmentation index in kidney transplant recipients.Tzu Chi Med J. 2018 Jul-Sep;30(3):152-157. doi: 10.4103/tcmj.tcmj_9_18. Tzu Chi Med J. 2018. PMID: 30069123 Free PMC article.
-
Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease.Ther Clin Risk Manag. 2018 Feb 5;14:231-236. doi: 10.2147/TCRM.S150476. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29440908 Free PMC article.
References
-
- Khoshdel AR, Carney SL. Arterial stiffness in kidney transplant recipients: an overview of methodology and applications. Urol J. 2008;5:3–14. - PubMed
-
- Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241:507–32. - PubMed
-
- Stoner L, Faulkner J, Lowe A, M Lambrick D, M Young J, Love R, et al. Should the augmentation index be normalized to heart rate? J Atheroscler Thromb. 2014;21:11–6. - PubMed
-
- Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J. 2010;74:24–33. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources